The medical technology sector represents one of the most lucrative and high-growth application verticals within the Microspheres Market, accounting for approximately USD 4.38 billion in revenue. Interventional radiology has been revolutionized by the FDA approval and adoption of yttrium-90 (Y-90) radioactive glass microspheres used in radioembolization (selective internal radiation therapy) to...